Skip to main content

Table 3 Demographics of NETs (Sample sets 1–3)

From: Gene network-based analysis identifies two potential subtypes of small intestinal neuroendocrine tumors

Sample set

Sample no.

Gender

Age range

Site

Metastases

Treatment#

1

T1

M

45-49

Ileum

N

N

1

T2

F

60-64

Ileum

N

N

1

T3

F

45-49

Ileum

N

N

1

T4

M

65-69

Ileum

N

N

1

T5

F

85-89

Ileum

N

N

1

T6

M

40-44

Ileum

N

N

1

T7

F

65-69

Ileum

N

N

1

T8

M

65-69

Ileum

N

N

1

T9

F

55-59

Ileum

N

N

2

T1

M

70-74

Ileum

N

N

2

T2

M

80-84

Ileocecal junction

N

N

2

T3

F

60-64

Ileum

N

N

2

T4

M

50-54

Liver*

Y

Y

2

T5

F

60-64

Liver*

Y

Y

2

T6

F

75-79

Liver*

Y

Y

3

T1

F

65-69

Ileum

N

N

3

T2

F

60-64

Ileum

Y

N

3

T3

M

65-69

Ileum

Y

Y

3

T4

M

65-69

Ileum

Y

Y

3

T5

F

60-64

Ileum

N

N

3

T6

M

75-79

Ileum

N

N

3

T7

F

60-64

Ileum

N

N

3

T8

F

55-59

Ileum

N

N

3

T9

M

40-44

Ileum

Y

N

3

T10

M

45-49

Ileum

N

N

3

T11

M

50-54

Ileum

N

N

3

T12

F

45-49

Ileum

N

N

3

T13

F

50-54

Ileum

Y

N

  1. #Treatment included somatostatin analogs and/or interferon [21].
  2. *All patients had carcinoid syndrome [21] so presumably the primary tumors were derived from the small intestine.
  3. Female = female, M = Male, N = No, Y = Yes.